Detalhe da pesquisa
1.
Real-world management patterns in EGFR-mutant advanced non-small-cell lung cancer before first-line adoption of osimertinib: the REFLECT study in Greece.
Future Oncol
; 18(28): 3151-3164, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35929414
2.
Immune profiling of melanoma tumors reflecting aggressiveness in a preclinical model.
Cancer Immunol Immunother
; 66(12): 1631-1642, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28871365
3.
A pilot study in prostate cancer patients treated with the AE37 Ii-key-HER-2/neu polypeptide vaccine suggests that HLA-A*24 and HLA-DRB1*11 alleles may be prognostic and predictive biomarkers for clinical benefit.
Cancer Immunol Immunother
; 64(9): 1123-36, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26026288
4.
AE37 peptide vaccination in prostate cancer: identification of biomarkers in the context of prognosis and prediction.
Cancer Immunol Immunother
; 63(11): 1141-50, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25052849
5.
AE37 peptide vaccination in prostate cancer: a 4-year immunological assessment updates on a phase I trial.
Cancer Immunol Immunother
; 62(10): 1599-608, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23934022
6.
Clinical Outcomes Beyond 1L EGFR-TKI Progression in mNSCLC: Final Results of the Real-World Study 'LUNGFUL'.
Anticancer Res
; 43(5): 2243-2258, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37097667
7.
Potential Prognostic Molecular Signatures in a Preclinical Model of Melanoma.
Anticancer Res
; 37(1): 143-148, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28011484
8.
Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer.
J Immunother Cancer
; 5: 39, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28428887
9.
Erratum to: Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer.
J Immunother Cancer
; 5: 48, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28572978
10.
Life as an early career researcher: interview with Eleftheria Anastasopoulou.
Future Sci OA
; 2(1): FSO111, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28031954
11.
Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide.
J Immunother Cancer
; 4: 75, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27891225
12.
MHC class II tetramer analyses in AE37-vaccinated prostate cancer patients reveal vaccine-specific polyfunctional and long-lasting CD4(+) T-cells.
Oncoimmunology
; 5(7): e1178439, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27622033
13.
Immune biomarkers: how well do they serve prognosis in human cancers?
Expert Rev Mol Diagn
; 15(1): 49-59, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25345403
14.
Further insight into AE37 peptide vaccination in prostate cancer.
Future Sci OA
; 3(3): FSO192, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28883993